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Abstract
Doublecortin-like kinase 1 (Dclk1), a microtubule-associated kinase, marks the fifth lineage
of intestinal epithelial cells called tuft cells that function as tumor stem cells in Apcmutant
models of colon cancer. In order to determine the role of Dclk1 in dextran sulfate sodium
(DSS) induced colonic inflammation both intestinal epithelial specific Dclk1 deficient
(VillinCre;Dclk1f/f) and control (Dclk1f/f) mice were fed 3% DSS in drinking water for 9 days,
allowed to recover for 2 days, and killed. The clinical and histological features of DSS-
induced colitis were scored and immunohistochemical, gene expression, pro-inflammatory
cytokines/chemokines, and immunoblotting analyses were used to examine epithelial bar-
rier integrity, inflammation, and stem and tuft cell features. In DSS-induced colitis, VillinCre;
Dclk1f/f mice demonstrated exacerbated injury including higher clinical colitis scores,
increased epithelial barrier permeability, higher levels of pro-inflammatory cytokines and
chemokines, decreased levels of Lgr5, and dysregulated Wnt/b-Catenin pathway genes.
These results suggest that Dclk1 plays an important role in regulating colonic inflammatory
response and colonic epithelial integrity.
Introduction
Inflammatory bowel disease (IBD), consisting mainly of Crohn’s disease and ulcerative colitis
is a chronic inflammatory disorder of the gastrointestinal tract caused by multiple factors
[1–3]. Several factors are involved in the pathogenesis of IBD, including the presence of IBD
susceptibility genes, altered microbial flora, excessive innate/adaptive immunity, defective
autophagy, and reduced mucosal epithelial barrier defense [1–3]. IBD causes dysregulation of
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many pathways involved in the maintenance of intestinal barrier integrity such as proliferation,
migration, differentiation, and cell death. These changes may eventually result in excessive tis-
sue injury, inadequate regeneration, and an increased risk of developing cancer [1,3,4].
The adult intestinal epithelium and its tight junctions form an essential barrier between the
organism and environmental factors including microorganisms. During homeostasis, the cells
of the intestinal epithelium are replaced by Lgr5+ rapidly cycling stem cells originating from
the crypt base [5,6]. When this process is disrupted it results in a loss of barrier integrity
compromising the intestine’s ability to respond to injury [4,5]. Doublecortin-like kinase 1
(Dclk1) is a microtubule-associated protein that marks long-lived, quiescent epithelial tuft cells
in the intestine, which originate from Lgr5+ cells [7–10]. A recent report utilizing a Dclk1-BAC
lineage tracing mouse model demonstrated that Apcmutant Dclk1+ colon cells respond to
inflammatory insult by initiating tumorigenesis [10]. Moreover, lineage tracing experiments
with another novel Dclk1 mouse model (Dclk1CreERT2) demonstrated that Dclk1+ cells are
tumor stem cells in Apcmin mice and that inducible ablation of these cells results in complete
and apparently non-toxic destruction of adenomas [9]. These findings suggest that DCLK1
may be an essential driver of APCmutant colorectal cancers.
Recently, we found that deleting Dclk1 in mouse intestinal epithelial cells results in impaired
epithelial restoration following radiation injury [11], suggesting that Dclk1 plays an important
role in response to intestinal injury. Colonic inflammation is one of the key factors that predis-
poses individuals to developing colon cancer [12]. In this report we characterize the effects of
ablating Dclk1 in intestinal epithelial cells on the colonic response to dextran sulfate sodium
(DSS)-induced colonic injury, a model that reproduces some features of human IBD. Our
results demonstrate that deletion of Dclk1 in intestinal epithelial cells results in severe damage
to the colon relative to control mice following DSS. These findings support an essential role for




All animal experiments were performed with the approval and authorization from the Institu-
tional Review Board and the Institutional Animal Care and Use Committee, University of
Oklahoma Health Sciences Center. Mice were housed under controlled conditions, including a
12-h light-dark cycle, with ad libitum access to food and water.
Experimental animals
The Dclk1tm1.2Jgg/J mouse (Dclk1f/f) and the B6.SJL-Tg(Vil-cre)997Gum/J mouse (VillinCre)
were purchased from The Jackson Laboratory (Bar Harbor, Maine). The VillinCre;Dclk1f/f
mouse line was generated as described previously [11]. Seven to eight-wk-old male VillinCre;
Dclk1f/f and Dclk1f/f mice were used in the experiments.
DSS treatment
To induce colitis, both VillinCre;Dclk1f/f and Dclk1f/f mice (n = 8 for each group) were fed with
dextran sulfate sodium (DSS, molecular weight, 36,000–50,000; MP Biomedicals, Solon, OH)
in drinking water (3%, wt/vol) for 9 days followed by drinking water alone for 2 days. Mice
were weighed daily and scored for colitis-associated symptoms, including stool consistency (0
being a normal stool – 4 being diarrhea) and presence of fecal blood (0 being no blood in the
feces, 1 being some blood in the feces, and 2 being bloody feces). At day 11, mice were killed by
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CO2 asphyxiation and colons were removed for further studies. The DSS treatment was
repeated twice with n = 5 for each group of mice.
Intestinal barrier integrity
Both VillinCre;Dclk1f/f and Dclk1f/f mice (n = 3) were fed with 200 μl of FITC-dextran at
600 mg/kg body weight (molecular weight, 4 kDa; Sigma-Aldrich) by gavage. Mice were killed
4 hours later by CO2 asphyxiation and blood was collected by heart puncture. The serum con-
centration of the FITC-dextran (excitation, 490 nm; emission, 530 nm) was determined using a
Synergy fluorometer plate reader (BioTek).
Immunohistochemistry
Heat-induced epitope retrieval was performed on 4-μm formalin-fixed paraffin-embedded sec-
tions by utilizing a pressurized Decloaking Chamber (Biocare Medical, Concord, CA) in citrate
buffer (pH 6.0) at 99°C for 18 min. For brightfield microscopy, slides were exposed to peroxi-
dase blocking solution prior to the addition of primary antibodies (anti-Dclk1 pAb ab31704,
anti-Lgr5 pAb ab137484, anti-Bmi1 pAb ab85688, anti-beta-Catenin pAb ab6302, anti-NF-κB
p65 pAb ab16502, and anti-Ki67 mAb ab16667 [Abcam, Cambridge, MA]). After incubation
with primary antibody overnight at 4°C, the slides were incubated in peroxidase-conjugated
polymer (Promark Series-Biocare Medical, CA). Slides were developed with either Betazoid
DAB or Bajoran Purple HRP chromogens (Biocare Medical). Slides were examined with a
Nikon 80i microscope and DXM1200C camera for brightfield microscopy. To detect apoptotic
cells, ApopTag Peroxidase in Situ Apoptosis Detection Kit was used following the manufactur-
er’s instructions (Millipore, Billerica, MA). The apoptotic cells were detected with anti-digoxi-
genin conjugated with FITC. Fluorescent images were taken with PlanFluoro objectives,
utilizing a CoolSnap ES2 camera (Photometrics, Tucson, AZ). Images were processed using
NIS-Elements software (Nikon Instruments, Melville, NY).
Real-time RT-PCR Analyses
Total RNA isolated from colon was subjected to reverse transcription using Superscript II
RNase H-Reverse Transcriptase and random hexanucleotide primers (Invitrogen, Carlsbad,
CA). The complementary DNA (cDNA) was subsequently used to perform real-time polymer-
ase chain reaction (PCR) by SYBR chemistry (SYBR Green I, Molecular Probes, Eugene, OR)
for specific transcripts using gene-specific primers and JumpStart Taq DNA polymerase
(Sigma-Aldrich, St. Louis, MO). The crossing threshold value assessed by real-time PCR was
noted for the transcripts and normalized with β-actin messenger RNA (mRNA). Quantitative
changes in mRNA were expressed as fold-change relative to control ± SEM value. The primer
sequences for gene analyzed are listed in Table 1.
Western Blot Analysis
Total proteins isolated from colon were subjected to Western blot analysis. The concentration
of total proteins was determined by BCA protein assay (Pierce, Rockford, IL). 40 micrograms
of total proteins were separated in a 7.5–15% SDS polyacrylamide gel and transferred onto a
nitrocellulose membrane with a semidry transfer apparatus (Amersham Pharmacia, Piscat-
away, NJ). The membrane was blocked in 5% non-fat dry milk for 1 hour and probed overnight
with a primary antibody. Subsequently the membrane was incubated with horseradish peroxi-
dase-conjugated secondary antibody for 1 hour at room temperature. The proteins were
detected using ECLWestern blotting detection reagents (Amersham-Pharmacia). Actin
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(43-kD) was used as loading control and identified using a goat polyclonal IgG (Santa Cruz
Biotechnology Inc., Dallas, Texas). The following antibodies were used: Dclk1 (ab31704)
(Abcam, Cambridge, MA), Claudin-1 (sc-137121), Claudin-5 (sc-28670), Claudin-7 (sc-
17670) (Santa Cruz Biotechnology, Dallas, TX), E-Cadherin (MA5-15711) (Life Technologies,
Carlsbad, CA), β-actin (4970), NF-κB p65 (D14E12) (Cell Signaling, Danvers, MA).
MPO activity Assay
Myeloperoxidase (MPO) activity, an index of neutrophil recruitment, was measured in colon
tissue homogenates by a modification of the method of Grisham [13]. Briefly, colon homoge-
nate was sonicated in 1% hexadecyltrimethyl-ammonium bromide buffer and subjected to cen-
trifugation at 12,000 RPM at 4°C for 20 min. MPO activity in the homogenates was measured
in triplicate using a Fluoro MPO detection kit (Cell Technology, Inc., CA) according to the
manufacturer’s instruction.
Measurement of colonic cytokines/chemokines
Colons from both VillinCre;Dclk1flox/flox and Dclk1flox/flox mice were isolated, and homogenized
in phosphate-buffered saline (PBS). Protein concentration was determined using BCA assay
(Thermo Scientific, Rockford, IL). The cytokine/chemokine concentration in the colonic
homogenates was measured in duplicates using a Bio-Plex Pro Mouse Cytokine 23-Plex Assay
kit (Bio-Rad, Hercules, CA) according to the manufacturer’s instruction.
Measurement of Wnt/b-Catenin pathway genes
The expression levels of mouse Wnt/b-Catenin regulated genes in colonic tissues were deter-
mined using Mouse Wnt/b-Catenin Regulated cDNA Plate Array (Signosis, Menlo Park, CA)
following the manufacturer’s instructions.
Statistical analysis
All experiments were performed in triplicate. Results were reported as average+/- SEM. Data
was analyzed using the Student’s t test for comparison of mean values between groups. A P
value<0.05 was considered statistically significant.
Table 1. Primer sequences for genes analyzed by real-time RT-PCR.
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Results
Characterization of intestinal epithelial deletion of Dclk1 under normal
conditions
To establish a mouse line with intestinal epithelial deletion of Dclk1, we selected the Villin pro-
moter to drive Cre-recombinase mediated excision of Dclk1 because it is specifically expressed
in nearly 100% of epithelial cells of the small intestine and colon with a few notable exceptions
including the brush border membrane in the proximal tubules of the kidney and glandular epi-
thelium of the gallbladder [14]. We crossbred the constitutively active VillinCre mouse line with
a mouse line with loxP sites flanking exon 3 of Dclk1 (Dclk1f/f), which is shared by all primary
mouse isoforms [11]. Recombination in the resulting VillinCre;Dclk1f/f mice, resulted in a com-
plete loss of Dclk1 protein in the colonic epithelium as demonstrated by immunohistochemis-
try using anti-Dclk1 antibody and this loss was also confirmed by real-time RT-PCR and
Western blot (Fig 1A–1C). Despite this dramatic loss of epithelial Dclk1, hematoxylin and
eosin (H&E) staining revealed no notable changes in the basal colonic architecture (Fig 2B).
The intestinal epithelium serves as an essential barrier against gut pathogens and is main-
tained by tight junction proteins (TJPs) [4,15]. In order to examine barrier integrity at baseline,
both VillinCre;Dclk1f/f and Dclk1f/f mice were gavaged with FITC-dextran, and serum FITC-
dextran levels were determined after 4 h using a fluorescent microplate reader. Basal levels of
FITC-dextran in the bloodstream were on average 20% higher in VillinCre;Dclk1f/f mice than in
Dclk1f/f mice and Western blot analysis showed a slight decrease in Claudin-1 but no other
TJPs (Fig 1C and 1D). These results support our previous findings [11], and suggest that Dclk1
has a modest role in maintaining barrier function during homeostasis.
Deletion of Dclk1 exacerbates colonic barrier dysfunction following DSS
treatment
DSS treatment in mice results in inflammation and colitis consistent with human IBD [16]. To
determine the effect of ablating Dclk1 in colonic epithelial cells on the response to
Fig 1. Characterization of intestinal epithelial deletion of Dclk1 under normal conditions. A. There is no
detectable Dclk1 in the colonic epithelia of VillinCre;Dclk1f/f mice. Colonic tissues stained with anti-Dclk1
antibody (Brown) under normal conditions (200x magnification). B. Dclk1 mRNA levels were dramatically
decreased in the VillinCre;Dclk1f/f mice; C. The expression levels of Dclk1 and TJPs in Dclk1f/f and VillinCre;
Dclk1f/f mice; D. Intestinal mucosal integrity was impaired in the VillinCre;Dclk1f/f mice. FITC-Dextran level in
the serum of each mouse was determined 4 h after gavage (n = 3 for each group, *p<0.02).
doi:10.1371/journal.pone.0134212.g001
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inflammatory injury, both VillinCre;Dclk1f/f and Dclk1f/f control mice were given 3% DSS in
drinking water for 9 days followed by 2 days of water only. All animals were killed on day 11
(Fig 2A) and H & E staining was performed to confirm successful induction of colitis in all
mice from both groups (Fig 2B).
Intestinal epithelial barrier integrity loss is thought to be the first event that underlies injury
and inflammation in many intestinal disorders, including IBD [17,18]. To investigate epithelial
Dclk1’s role in maintaining intestinal barrier integrity following DSS treatment, both VillinCre;
Dclk1f/f and Dclk1f/f mice were gavaged with FITC-Dextran before being killed, and serum
FITC-dextran levels were determined after 4 hours using a fluorescent microplate reader.
FITC-dextran levels in the bloodstream were dramatically increased in both groups of mice rel-
ative to baseline (Fig 2D), and were significantly higher in DSS-treated VillinCre;Dclk1f/f mice
relative to DSS-treated Dclk1f/f mice (Fig 2D and 2E). Moreover, Western blot analysis indi-
cated significant decreases in TJPs Claudin-7 and E-cadherin, and moderate decreases in Clau-
din-1, -5 (Fig 2C). These results demonstrate that loss of epithelial Dclk1 further compromises
barrier integrity following inflammatory injury of the colon and support our previous findings
that Dclk1 is essential to maintaining barrier integrity through TJPs following intestinal injury
[11].
Deletion of Dclk1 increases epithelium apoptosis and decreases
epithelium proliferation following DSS treatment
The colonic epithelial response to DSS injury was also assessed in terms of cell apoptosis and
proliferation, which are both important factors in regeneration following injury. Apoptotic
cells were identified by TUNEL assay (Fig 3), and there was a slight increase in apoptotic cells
detected in VillinCre;Dclk1f/f relative to Dclk1f/f control mice. To examine the effect of ablating
Dclk1 on colonic epithelium proliferation, colonic tissues were stained with anti-Ki67 antibody
Fig 2. Deletion of Dclk1 exacerbates colonic barrier dysfunction following DSS treatment. A.
Experimental plan; B. H&E staining demonstrated normal histology in VillinCre;Dclk1f/f and Dclk1f/f mice at
baseline and confirmed a significant inflammatory response following DSS treatment (200x magnification) C.
Western blot analysis of tight junction and adherens junction proteins demonstrated a decrease in Claudin-1,
Claudin-7, and E-cadherin in the VillinCre;Dclk1f/f mice after DSS treatment;D. FITC-Dextran levels in the
serum of each mouse were determined 4 h after gavage in baseline and post DSS treatment (n = 5 for post
DSS groups, *p<0.02, **** p<0.0001 VillinCre;Dclk1f/f vs Dclk1f/f); E. Fold change of FITC-Dextran levels in
the VillinCre;Dclk1f/f mice post DSS treatment.
doi:10.1371/journal.pone.0134212.g002
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(Fig 3), and proliferative colonic crypts were identified in Dclk1f/f control mice, but the pres-
ence of Ki67+ proliferative cells in VillinCre;Dclk1f/f mice crypts was negligible. These results
demonstrate that Dclk1 plays an important role in epithelial apoptosis and proliferation fol-
lowing injury.
Deletion of Dclk1 exacerbates DSS-induced inflammation of the colonic
mucosa
In the gut, IBD is characterized by extensive neutrophil infiltration [19], which is related to the
severity of inflammation. In order to determine the level of neutrophil infiltration we quanti-
fied myeloperoxidase (MPO) activity in the colon tissues of DSS-treated mice. Following DSS,
MPO activity was more than 3 fold higher in VillinCre;Dclk1f/f mice compared to Dclk1f/f mice
(Fig 4A), suggesting a dramatic increase in neutrophil infiltration in intestinal epithelial Dclk1
deficient mice. Pro-inflammatory cytokines and chemokines produced by activated neutrophils
play an important role in mediating tissue inflammation and injury, and prostaglandin-endo-
peroxide synthase 2 (Ptgs2/Cox2) is selectively induced by proinflammatory cytokines at the
site of inflammation [20]. Ptgs2 mRNA levels were approximately 6 fold higher in the colon tis-
sue of VillinCre;Dclk1f/f mice relative to Dclk1f/f after DSS treatment (Fig 4B). Consistent with
this finding, the mRNA expression levels of several pro-inflammatory cytokines and chemo-
kines including Il6, Il1β, Cxcl1, and Cxcl2 were also 4–6 fold higher in the colon of VillinCre;
Dclk1f/f mice relative to control mice after DSS treatment (Fig 4B). Nuclear factor kappa B
(NF-κB) is a family of ubiquitously expressed transcription factors that strongly influences the
course of mucosal inflammation [21]. Western blot analysis demonstrated upregulation of the
RelA (p65) subunit of NF-κB in the colon of both groups of mice following DSS treatment and
its expression was significantly increased in DSS-treated VillinCre;Dclk1f/f mice relative to
Dclk1f/f mice (Fig 4C). In addition, colonic tissues were also stained with anti-RelA antibody,
and there was a significantly increased RelA expression detected in VillinCre;Dclk1f/f relative to
Dclk1f/f control mice with occasional nuclear localization of RelA found in VillinCre;Dclk1f/f
mice but not in Dclk1f/f control mice (Fig 5).
Fig 3. Deletion of Dclk1 increases epithelial apoptosis and decreases epithelial proliferation following
DSS treatment. A. Apoptotic cells (Green) identified by TUNEL assay;B. Proliferative cells identified by
immunostaining with anti-Ki67 antibody.
doi:10.1371/journal.pone.0134212.g003
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To further investigate this phenomenon we measured the levels of 23 cytokines and chemo-
kines in treated and untreated colon tissue of both mouse strains using a magnetic-bead based
immunoassay. We found increased expression of both cytokines and chemokines in VillinCre;
Dclk1f/f mice relative to Dclk1f/f mice after DSS treatment (Fig 6A). Particularly, the proinflam-
matory structural cytokines IL-1α, IL-1β, and IL-17 and the proinflammatory chemokines
Cxcl1, Ccl2, Ccl3, and Ccl5, were upregulated further in the VillinCre;Dclk1f/f mice compared
to Dclk1f/f mice (Fig 6B and 6C). Collectively, these results support our hypothesis that deleting
Dclk1 in the intestinal epithelium increases tissue inflammation following injury. Additionally,
these results suggest that Dclk1 regulates NF-κB expression, and may have a direct role in regu-
lating the inflammatory response to DSS-induced injury.
Deletion of Dclk1 exacerbates clinical features of colitis following DSS
treatment
DSS-induced injury reproduces some clinical features of human colitis including weight loss,
diarrhea, and bloody stools [16]. At baseline and throughout the course of treatment we
tracked these features on a daily basis. As expected, the body weights in both groups of mice
were decreased after DSS treatment. However, towards the end of treatment the percentage of
body weight loss in VillinCre;Dclk1f/f mice was higher than in Dclk1f/f mice (Fig 7A). Besides
weight loss, diarrhea and bloody stools were observed in both groups of mice, and significantly
Fig 4. Deletion of epithelial Dclk1 exacerbates DSS-induced inflammation of the colonic mucosa. A. Colonic MPO activity was dramatically increased
in the VillinCre;Dclk1f/f mice following DSS treatment;B. The mRNA expression levels of Ptgs2, Il6, Il1β, Cxcl1, and Cxcl2 in colonic tissues were measured
by quantitative real-time RT-PCR, and normalized against β-actin. Values in the bar graphs are given as mean ± SEM, *p<0.02, **** p<0.0001 VillinCre;
Dclk1f/f vs Dclk1f/f; C. The protein expression level of RelA in colonic tissues was analyzed byWestern blotting.
doi:10.1371/journal.pone.0134212.g004
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more severe diarrhea and fecal blood resulted from DSS-treatment of VillinCre;Dclk1f/f mice
compared to Dclk1f/f mice (Fig 7B and 7C). The combination of these two scores indicated a
consistently and significantly higher disease activity in VillinCre;Dclk1f/f mice (Fig 7D). Conse-
quently, during the course of DSS treatment, all Dclk1f/f mice survived, while approximately
Fig 5. Deletion of Dclk1 increases NF-κB expression following DSS treatment. The expression of NF-κB p65 (Brown) was identified by immunostaining
with anti-p65 antibody. Occasional nuclear localization of p65 was indicated by arrow in VillinCre;Dclk1f/f mice. Alcian blue was used for counterstaining.
doi:10.1371/journal.pone.0134212.g005
Fig 6. Epithelial deletion of Dclk1 upregulates pro-inflammatory cytokines and chemokines after DSS treatment. A. Heatmap of Bio-Plex Pro Mouse
Cytokine 23-Plex Assay results. B. The individual expression levels of structural cytokines, IL-1α, IL-1β, IL-10, and IL17.C. The individual expression levels
of chemokines, Cxcl1, Ccl2, Ccl3, and Ccl5.
doi:10.1371/journal.pone.0134212.g006
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35% of VillinCre;Dclk1f/f mice died following DSS treatment (Fig 7E). These findings demon-
strate that deletion of Dclk1 in intestinal epithelium exacerbates the clinical features of DSS-
induced colitis resulting in increased mortality.
Deletion of epithelial Dclk1 alters the intestinal tuft and stem cell
signature
In order to determine the effect of deleting Dclk1 in intestinal epithelial cells on intestinal tuft
and stem cell populations before and after DSS treatment, we measured the mRNA expression
levels of signature genes from these cell populations. Ptgs1 (Cox1), a prominent tuft cell
marker, was not affected by DSS treatment in Dclk1f/f mice, but was decreased approximately
30% in VillinCre;Dclk1f/f mice following DSS treatment (Fig 8A). Although tuft cell marker
Dclk1 mRNA appeared slightly decreased in Dclk1f/f mice following treatment this decrease
was not significant (Fig 8B).
To assess the effects of DSS treatment on both actively cycling stem cell and reserve stem
cell populations, the mRNA expression levels of Lgr5 and Bmi1 were determined. The expres-
sion level of cycling stem cell marker Lgr5 was decreased more than 50%, and the expression
level of Bmi1 decreased about 20% in Dclk1f/f mice after DSS treatment (Fig 8C and 8D), sug-
gesting a decrease in both stem cell populations following DSS-induced colitis. Moreover, Lgr5
expression levels were further decreased in VillinCre;Dclk1f/f mice compared to Dclk1f/f mice
after DSS treatment (Fig 8D) while Bmi1 expression levels were dramatically upregulated in
Fig 7. Dclk1 epithelial deletion increases disease activity following DSS-induced colitis. Both VillinCre;Dclk1f/f and Dclk1f/f mice were fed with 3% DSS
in drinking water for 9 days followed by regular drinking water for 2 days to induce colitis (n = 8 for each group). A. Body weight.B. Diarrhea score. C. Fecal
blood score. D. Disease activity index. E. Kaplan-Meier survival curve (dashed line = VillinCre;Dclk1f/f, solid line = Dclk1f/f). Data are presented as the
mean ± S.E.M. *p<0.05 VillinCre;Dclk1f/f vs Dclk1f/f.
doi:10.1371/journal.pone.0134212.g007
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VillinCre;Dclk1f/f mice compared to Dclk1f/f mice after DSS treatment (Fig 8C). In confirmation
of these findings, decreased expression of Lgr5 and increased expression of Bmi1 in distal
colon tissues post DSS treatment were also observed in VillinCre;Dclk1f/f mice by immunostain-
ing (Fig 8E). This may suggest activation of the Bmi1+ reserve stem cell population in response
to the exacerbated injury present in the VillinCre;Dclk1f/f mice and a potential compensatory
mechanism for the loss of Dclk1.
Discussion
Intestinal barrier dysfunction is an integral feature of IBD including Crohn’s disease and ulcer-
ative colitis. Barrier disruption in IBD compromises epithelial tight junctions due to reduced
TJP expression and dysregulated subcellular localization. The consequences of these barrier-
related defects are often exacerbated by increased pro-inflammatory cytokine and chemokine
activity in the inflamed colon. Although the precise etiology of IBD remains unclear, chronic
inflammation is associated with poor immune response resulting from genetic predispositions,
altered populations of the intestinal microbiome, and deficient responses to these populations
[3,15].
The DSS model is a well-characterized chemical irritant mouse model that begins with barrier
disruption thereby encompassing a key feature of human IBD [16]. The resultant loss of direct
and indirect regulation of genes and pathways critical to the recovery process is a key element in
the response to DSS-related injury. Structurally, tuft cells are still present in VillinCre;Dclk1f/f
Fig 8. Deletion of epithelial Dclk1 alters the intestinal tuft and stem cell signature. Total RNAs were isolated from colonic tissue. The mRNA expression
levels of Dclk1, Ptgs1, Lgr5, and Bmi1 (A, B, C, D) were measured by quantitative real-time RT-PCR, and normalized against β-actin (dashed bar = VillinCre;
Dclk1f/f, open bar = Dclk1f/f). Values in the bar graphs are given as mean ± SEM and *, **, ***, **** denote statistically significant differences (p<0.05,
<0.005, <0.0005, 0.00005 respectively). E. Colonic tissues were stained with anti-Lgr5 and anti-Bmi1 antibodies (Brown) post DSS treatment. F. The
expression levels of mouseWnt/b-Catenin regulated genes in colonic tissues were determined using MouseWnt/b-Catenin Regulated cDNA Plate Array.
doi:10.1371/journal.pone.0134212.g008
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knockout mice and this study again implicates Dclk1 in the maintenance of barrier integrity and
as a regulator of factors affecting survival in acute severe cytotoxic colonic injury [10,11].
In this report we provide a detailed assessment of the cytokine and chemokine profiles of Vil-
linCre;Dclk1f/f mice with genetically depleted intestinal and colonic Dclk1. The dramatically exag-
gerated chemokine and cytokine expression profile supports a critical role for Dclk1-based
regulation of pro-inflammatory mediators as well as the notion that the Dclk1 regulatory balance
is required for adequate restitution of injury-mediated barrier disruption. These findings are
consistent with a recent report in which diphtheria-toxin driven ablation of Dclk1+ tuft cells was
utilized, and demonstrate that, in terms of survival which was nearly the same in the aforemen-
tioned study and the present study, the loss of Dclk1 protein alone is comparable to the loss of
the entire tuft cell [10]. Additionally this study illustrates a potential mechanistic delineation of
the effects of barrier dysfunction and Dclk1-mediated regulation of the inflammatory response
that was not explored in the tuft cell deletion model used byWestphalen et. al [10].
Although multiple lines of evidence indicate that Dclk1 is a regulator of stem cells in the
intestinal niche [10,11,22], questions remain about the extent to which Dclk1 protein regulates
the tuft cell’s chemosensory and secretory functions and how this affects the intestinal stem cell
niche. RNA-seq analysis of the small intestinal epithelium of VillinCre;Dclk1f/f knockout mice
demonstrates dysregulation of key chemosensory and secretory markers such as guanylin, uro-
guanylin, proenkephalin, proopiomelanocortin, and various taste receptors which may modu-
late stem cell dynamics and function [11]. In order to assess whether the loss of Lgr5
expression in VillinCre;Dclk1f/f mice may be related to dysregulation of Wnt/β-Catenin signal-
ing, we used an RT-PCR array to measure expression levels of selected Wnt pathway genes. We
found dysregulated expression at baseline and following DSS in VillinCre;Dclk1f/f mice com-
pared to Dclk1f/f mice suggesting that Dclk1 is an active regulator of Lgr5 andWnt signaling
(Fig 8F). In addition, immunohistochemical studies indicated that there is a significantly
increased nuclear localization of β-Catenin in colonic crypts detected in VillinCre;Dclk1f/f rela-
tive to Dclk1f/f control mice (Fig 9), suggesting that the WNT-β-Catenin signaling pathway is
still very active in the knockout mice while the control epithelium has already regenerated.
Moreover, proliferative colonic crypts, as marked by Ki67+ cells, were barely identifiable in
VillinCre;Dclk1f/f mice following DSS treatment (Fig 3), suggesting that deletion of Dclk1 in
colonic epithelium retards the β-Catenin-driven crypt regeneration process in response to
Fig 9. Immunohistochemical staining of β-Catenin in colon tissues following DSS treatment. The expression of β-Catenin (Brown) was identified by
immunostaining with anti- β-Catenin antibody. Increased expression and increased nuclear localization of β-Catenin were found in VillinCre;Dclk1f/f relative to
Dclk1f/f mice. Alcian blue was used for counterstaining.
doi:10.1371/journal.pone.0134212.g009
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severe injury somewhere downstream of β-Catenin nuclear translocation. Further WNT-cen-
tric studies will be necessary to understand this crosstalk between this important pathway,
Dclk1, and the Dclk1+ tuft cell.
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